Most importantly, they think this new detection method may save thousands of lives annually. Camera-ready illustration of DNA cells shed from polyp. Video soundbites from study's principle investigator, Dr. David Ahlquist, and from a patient involved in the study, along with associated b-roll. Animation of the natural shedding of DNA cells to be captured in the stool and passed through the body. The video, including soundbites and animation, will be fed via video and audio feed during the news conference.
Additional information includes audio soundbites for radio and illustration for print medium.
Although about two years away from becoming widely available for public use, Mayo Clinic researchers believe this new method could significantly change the way screening for colorectal cancer is done. Most importantly, they think this new detection method may save thousands of lives annually. Measuring specific DNA abnormalities that are unique to precancerous polyps and early stage cancer results in high accuracy of detection. That's important because by detecting polyps and endoscopically removing them, we know that colorectal cancer can be prevented. The next step is for the DNA colorectal cancer test to undergo another phase of clinical trials, scheduled to begin this January.